Spotlight: Implications of Just Published New PTAB Rules
The use of inter partes review (IPR) to challenge bio/pharma patents has grown significantly — with the number nearly doubling in 2015 alone. While relatively few of them have reached final decisions, what gives some challengers the winning edge?
Please join our experienced attorneys for a discussion on the key challenges you could face with your next IPR, as well as your overall strategies for patent litigation and enforcement, and how to prepare to address them.
Topics include:
- Determining trends based on the first 105+ bio/pharma IPR petitions to be filed
- Discovering the most vulnerable types of bio/pharma patents
- Learning how to prosecute bio/pharma patents to withstand IPR
- Employing tactics to help prevent an institution decision
- Understanding more about biosimilar and biologics-related IPRs
- Reviewing updates on PTAB rule changes
Speakers
Stephen Maebius, Partner, IP Department, Foley & Lardner LLP
Kristel Schorr, Partner and Chair, Chemical, Biotechnology & Pharmaceutical Practice, Foley & Lardner LLP
Moderator
Etsuo Doi, Managing Partner, Tokyo Office, Foley & Lardner LLP
People
Related Insights
18 April 2024
Events
2024 Global Cyber Security Initiative (GCSI 2024) 5th Annual Conference
Foley partner Aaron Tantleff, a member of the firm’s Technology Transactions, Cybersecurity, and Privacy Practice, is participating as one of two distinguished keynote speakers at the GCSI 5th Annual Conference in Chicago on April 18.
17 April 2024
Manufacturing Industry Advisor
International Compliance and Risk-Mitigation Heat Map (2024 Update)
These interactive international compliance and risk-mitigation heat maps present quick visual indications of relative bribery, sanctions, and human rights compliance risks in every country around the globe.
23 April 2024
Events
HIN Chicago Debut: Greek Startups and the Greek Entrepreneurial Ecosystem
Join us for HIN's Chicago debut with an evening of networking and inspiration as Jimmy Samartzis, CEO of LanzaJet, tells us about his journey, the state of the CleanTech industry, and opportunities for entrepreneurs.